Fig 1: MTT assay results for compounds 17, 20, 21 and 22. MTT HT29: human colon adenocarcinoma cell line (ATCC No. HTB-38) MTT test results; MTT CCD 841 CoTr: human normal colon epithelial cells (ATCC No. CRL-1807) MTT test results.
Fig 2: Graphs showing activity of compounds 17, 20, 21 and 22 during the neutral red uptake NR assay. NR HT29: human colon adenocarcinoma cell line (ATCC No. HTB-38) neutral red uptake NR assay results; NR CCD 841 CoTr: human normal colon epithelial cells (ATCC No. CRL-1807) neutral red uptake NR assay results.
Fig 3: Nitric oxide (NO) measurement results for compounds 17, 20, 21, 22. HT29 Nitric oxide: human colon adenocarcinoma cell line (ATCC No. HTB-38) nitric oxide (NO) measurement results; CCD 841 CoTr Nitric oxide: human normal colon epithelial cells (ATCC No. CRL-1807) nitric oxide (NO) measurement results.
Fig 4: MTT assay results for compounds 17, 20, 21 and 22. MTT HT29: human colon adenocarcinoma cell line (ATCC No. HTB-38) MTT test results; MTT CCD 841 CoTr: human normal colon epithelial cells (ATCC No. CRL-1807) MTT test results.
Fig 5: Nitric oxide (NO) measurement results for compounds 17, 20, 21, 22. HT29 Nitric oxide: human colon adenocarcinoma cell line (ATCC No. HTB-38) nitric oxide (NO) measurement results; CCD 841 CoTr Nitric oxide: human normal colon epithelial cells (ATCC No. CRL-1807) nitric oxide (NO) measurement results.
Supplier Page from ATCC for CCD 841 CoTr